Cite
TRIP6 promotes tumorigenic capability through regulating FOXC1 in hepatocellular carcinoma.
MLA
Wang, Feiran, et al. “TRIP6 Promotes Tumorigenic Capability through Regulating FOXC1 in Hepatocellular Carcinoma.” Pathology - Research & Practice, vol. 216, no. 4, Apr. 2020, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.prp.2020.152850.
APA
Wang, F., Zhang, B., Xu, X., Zhu, L., & Zhu, X. (2020). TRIP6 promotes tumorigenic capability through regulating FOXC1 in hepatocellular carcinoma. Pathology - Research & Practice, 216(4), N.PAG. https://doi.org/10.1016/j.prp.2020.152850
Chicago
Wang, Feiran, Bo Zhang, Xiaodong Xu, Lirong Zhu, and Xiaochao Zhu. 2020. “TRIP6 Promotes Tumorigenic Capability through Regulating FOXC1 in Hepatocellular Carcinoma.” Pathology - Research & Practice 216 (4): N.PAG. doi:10.1016/j.prp.2020.152850.